Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-26T03:01:54.219Z Has data issue: false hasContentIssue false

TLR9 Rs352140 polymorphism contributes to a decreased risk of bacterial meningitis: evidence from a meta-analysis

Published online by Cambridge University Press:  04 November 2020

Haiyi Xue
Affiliation:
Department of Critical Care Medicine, Sichuan Cancer Hospital & Institute, Chengdu610041, People's Republic of China
Huan Peng
Affiliation:
Department of Critical Care Medicine, Sichuan Cancer Hospital & Institute, Chengdu610041, People's Republic of China
Jiaoming Li
Affiliation:
Department of Neurosurgery, Sichuan Cancer Hospital & Institute, Chengdu610041, People's Republic of China
Mingming Li
Affiliation:
Department of Neurosurgery, Chengdu Western Hospital, Chengdu610036, People's Republic of China
Song Lu*
Affiliation:
Department of Critical Care Medicine, Sichuan Cancer Hospital & Institute, Chengdu610041, People's Republic of China
*
Author for correspondence: Song Lu, E-mail: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Some studies have suggested that the Toll-like receptor 9 polymorphism (TLR9 rs352140) is closely related to the risk of bacterial meningitis (BM), but this is subject to controversy. This study set out to estimate whether the TLR9 rs352140 polymorphism confers an increased risk of BM. Relevant literature databases were searched including PubMed, Embase, the Cochrane Library and China National Knowledge Infrastructure (CNKI) up to August 2020. Seven case-control studies from four publications were enrolled in the present meta-analysis. Odds ratios (OR) and confidence intervals (95% CI) were calculated to estimate associations between BM risk and the target polymorphism. Significant associations identified were allele contrast (A vs. G: OR 0.66, 95% CI 0.59–0.75, P = 0.000), homozygote comparison (AA vs. AG/GG: OR 0.62, 95% CI 0.49–0.78, P = 0.000), heterozygote comparison (A vs. G: OR 0.74, 95% CI 0.61–0.91, P = 0.005), recessive genetic model (AA vs. AG/GG: OR 0.78, 95% CI 0.65–0.93, P = 0.006) and dominant genetic model (AA vs. AG/GG: OR 0.70, 95% CI 0.57–0.85, P = 0.000). The findings indicate that, in contrast to some studies, the TLR9 rs352140 polymorphism is associated with a decreased risk for BM.

Type
Original Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2020. Published by Cambridge University Press

Introduction

Bacterial meningitis (BM) is a common central nervous system infection associated with high mortality, and which has a significant negative impact on children's perception abilities [Reference Somand and Meurer1, Reference de Jonge2]. Early rapid diagnosis and timely treatment are key factors affecting its prognosis. At present, the diagnosis depends mainly on clinical characteristics and microbial and biochemical analysis of cerebrospinal fluid (CSF). However, non-specific clinical presentation and atypical changes in CSF composition can make it difficult to confirm the diagnosis of BM and distinguish it from viral meningitis and intracranial infection. As a consequence, there is an urgent need to identify reliable biomarkers for BM.

Various reports have demonstrated that pathogen recognizing receptors, especially Toll-like receptors (TLRs), play a vital role in modulating the host and immune responses to infection [Reference Underhill3Reference Jimenez-Dalmaroni, Gerswhin and Adamopoulos6]. Besides activating immune responses, TLRs aid the elimination of bacteria and virus infections and play a key role in the innate immunity against microbial pathogens [Reference Jo7]. TLR9 has been suggested to regulate unmethylated cytosine-phosphate-guanine movement and influence the production of pro-inflammatory and anti-inflammatory cytokines [Reference Hemmi8, Reference Sanders9]. TLR9 gene polymorphisms have also been associated with multiple diseases such as pulmonary tuberculosis, duodenal ulcers and altered cytokines in gastric mucosa, systemic lupus erythematosus and chronic obstructive pulmonary disease [Reference Bharti10Reference Wujcicka14]. Of these polymorphisms, the rs352140 variant has been the one most investigated, and some have suggested that it is significantly associated with susceptibility to BM [Reference Wang, Shi and Li15], but this has not been supported by other studies [Reference Sanders9, Reference van Well16, Reference Gowin17]. We therefore set out in this study to establish through a meta-analysis of published data whether TLR9 rs352140 polymorphism confers an increased risk for BM.

Materials and methods

Search strategy

The databases PubMed, Embase, the Cochrane Library and the China National Knowledge Infrastructure were searched by applying the words: (‘TLR9’ or ‘Toll-like receptor 9’) together with (‘BM’ or ‘Bacterial meningitis’) up to the end of August 2020.

Inclusion and exclusion criteria

The inclusion criteria met the following: (a) a case-control study; (b) reporting an assessment of association between TLR9 rs352140 polymorphism and BM risk; (c) offering sufficient information to allow the determination of OR and 95% CI values. Other publications such as letters and reviews were not included.

Data extraction

Relevant information was extracted by the first and second authors and contradictory data or information was reassessed by the corresponding author. Ethical approval of our study was waived by the Ethics Committee of Sichuan Cancer HospitalInstitute as no human or animal was directly enrolled in the study.

Statistical analysis

The association power was assessed through the corresponding indexes including OR and 95% CI with the application of the Q- and I 2 statistics [Reference Higgins and Thompson18, Reference Higgins19]. Four genetic models were applied including allele contrast (A vs. G), homozygote comparison (AA vs. GG), recessive genetic model (AA vs. GA/GG) and dominant genetic model (AA/GA vs. GG). The models of fixed-effects and random-effects were utilised to assess the degree of heterogeneity [Reference Mantel and Haenszel20, Reference DerSimonian and Laird21] while Funnel plots and Egger's test were used to identify publication bias [Reference Begg and Mazumdar22]. The Hardy–Weinberg Equilibrium (HWE) which states that ‘genotype frequencies in a population remain constant between generations in the absence of disturbance by outside factors’ [Reference Edwards23] was used to assess the validity of the published series; only studies with control groups having a P value for the HWE > 0.05 were included. All statistical analyses were performed using Stata 12.0 (Stata Corporation, Los Angeles, USA).

Results

Meta-analysis studies

Figure 1 shows the flow chart of meta-analysis search course. Based on the search strategy, four studies reporting seven groups of patients – three comprising both meningococcal (MM) and pneumococcal (PM) cases [Reference Sanders9, Reference van Well16, Reference Gowin17], and one reporting BM cases as a whole were identified [Reference Wang, Shi and Li15] (Table 1). All but Wang's study used population-based controls.

Fig. 1. Flow diagram for identification of eligible studies for this meta-analysis.

Table 1. Main characteristics of the case-control studies included in meta-analysis

HWE, Hardy–Weinberg equilibrium; PM, pneumococcal meningitis; MM, meningococcal meningitis.

Meta-analysis results

The results of the meta-analysis of the association of TLR9 rs352140 polymorphism and BM susceptibility are shown in Table 2 and Supplementary Material. Positive associations were found by allele contrast (A vs. G: OR 0.66, 95% CI 0.59–0.75, P = 0.000), homozygote comparison (AA vs. AG/GG: OR 0.62, 95% CI 0.49–0.78, P = 0.000), recessive genetic model (AA vs. AG/GG: OR 0.78, 95% CI 0.65–0.93, P = 0.006) and dominant genetic model (AA vs. AG/GG: OR 0.70, 95% CI 0.57–0.85, P = 0.000)

Table 2. Meta-analysis of the TLR9 rs352140 polymorphism with BM risk

PM, pneumococcal meningitis; MM, meningococcal meningitis.

No significant heterogeneity was found in any genetic model (P > 0.1 and I 2 < 50%) and the results of each of the single studies did not alter the key associations shown by the meta-analysis. We did not find any obvious asymmetry in the funnel plot (P = 0.107) (figure not shown), and there was also no evident publication bias by Egger's test in the recessive genetic model (P = 0.194).

Discussion

Although several pathogenic microorganisms may cause infection of the meninges, relatively few bacterial species, namely – Streptococcus pneumoniae, Neisseria meningitidis, Escherichia coli and Listeria monocytogenes are associated with the majority of cases [Reference Davis24]. BM is a common acute infection of the central nervous system in children. In developed countries, its incidence is reported to range from 1.4 to 6/100 000, with a fatality rate of approximately 5% [Reference Tan25]. The incidence rate in developing countries is more than 10 times higher and accompanied by a higher fatality rate [Reference Klinger26]. Moreover, 10–20% of survivors have some neurological sequelae including cognitive or visual impairment, bilateral hearing loss, movement disorders and epilepsy which impact significantly on patients' life conditions. It is widely recognised that several factors contribute to susceptibility to BM. Subjects most at risk of high mortality and morbidity are the newborn, particularly in poor countries, and exposed to bacterial infections, especially due to Gram-negative bacilli and S. pneumoniae [Reference Stevens27Reference de Louvois, Halket and Harvey29]. Apart from the impact of demographic factors such as age, environment and living conditions, genetic predisposition to BM has been considered as a significant contributor to the disease occurrence. The relationship between the TLR9 rs352140 polymorphism and susceptibility to BM has been investigated since 2011 [Reference Sanders9] but no firm conclusion regarding such an association has emerged. A meta-analysis of relevant published studies was therefore warranted, and to the best of our knowledge, this investigation is the first to study the specific relationship between TLR9 rs352140 polymorphism and BM susceptibility. The analysis indicated that this polymorphism is more associated with a decreased risk to BM. We consider that such a conclusion is reliable according to the heterogeneity test, sensitivity analysis and publication bias matrices. Furthermore, each of the studies analysed satisfied the HWE which states that allele and genotype frequencies in a defined population will remain constant from generation to generation in the absence of other evolutionary influences.

This study has some limitations. Notably, the total sample size could be considered to be insufficient owing to the lack of relevant well-designed original studies with a greater number of patients; such studies remain urgently needed. Secondly, a wider range of ethnicities are warranted to give a greater variety of racial and genetic backgrounds. Lastly, the four studies analysed did not take into consideration confounding factors such as age, gender and radiation exposure which might have contributed to some bias in our results.

In conclusion, our meta-analysis of the available studies in the literature indicates that, in contrast to some studies, the TLR9 rs352140 polymorphism is associated with a decreased risk for BM.

Supplementary material

The supplementary material for this article can be found at https://doi.org/10.1017/S0950268820002666.

Availability of data and materials

The datasets used and/or analysed during the present study are available from the corresponding author on reasonable request.

Author contributions

Conceived and designed the experiments: SL; performed the experiments: HX HP JL ML; analysed the data: HX HP JL ML; contributed reagents/materials/analysis tools: JL ML; wrote the paper: HX HP SL.

References

Somand, D and Meurer, W (2009) Central nervous system infections. Emergency Medicine Clinics of North America 27, 89100.CrossRefGoogle ScholarPubMed
de Jonge, RC et al. (2010) Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies. BMC Infectious Diseases 10, 232.CrossRefGoogle ScholarPubMed
Underhill, DM (2004) Toll-like receptors and microbes take aim at each other. Current Opinion in Immunology 16, 483487.CrossRefGoogle ScholarPubMed
Becker, CE and O'Neill, LA (2007) Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs. Seminars in Immunopathology 29, 239248.CrossRefGoogle ScholarPubMed
Brouwer, MC, Read, RC and van de Beek, D (2010) Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis. Lancet Infectious Diseases 10, 262274.CrossRefGoogle ScholarPubMed
Jimenez-Dalmaroni, MJ, Gerswhin, ME and Adamopoulos, IE (2016) The critical role of toll-like receptors – from microbial recognition to autoimmunity: a comprehensive review. Autoimmunity Reviews 15, 18.CrossRefGoogle ScholarPubMed
Jo, EK (2008) Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs. Current Opinion in Infectious Diseases 21, 279286.CrossRefGoogle ScholarPubMed
Hemmi, H et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408, 740745.CrossRefGoogle ScholarPubMed
Sanders, MS et al. (2011) Single nucleotide polymorphisms in TLR9 are highly associated with susceptibility to bacterial meningitis in children. Clinical Infectious Diseases 52, 475480.CrossRefGoogle ScholarPubMed
Bharti, D et al. (2014) The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis. Immunogenetics 66, 675681.CrossRefGoogle ScholarPubMed
Berenson, CS et al. (2015) Impaired innate COPD alveolar macrophage responses and Toll-like receptor-9 polymorphisms. PLoS ONE 10, e0134209.CrossRefGoogle ScholarPubMed
Trejo-de la, OA et al. (2015) Polymorphisms in TLR9 but not in TLR5 increase the risk for duodenal ulcer and alter cytokine expression in the gastric mucosa. Innate Immunity 21, 706713.CrossRefGoogle Scholar
Wen, SJ et al. (2015) Associations of genetic polymorphisms of TLR5, TLR9 and transduction molecules in MyD88 signaling pathway with systemic lupus erythematosus in Zhuang and Han ethnics of Guangxi province, China. International Journal of Clinical and Experimental Medicine 8, 78727880.Google Scholar
Wujcicka, W et al. (2015) Possible role of TLR4 and TLR9 SNPs in protection against congenital toxoplasmosis. European Journal of Clinical Microbiology & Infectious Diseases 34, 21212129.CrossRefGoogle ScholarPubMed
Wang, XH, Shi, HP and Li, FJ (2016) Association between Toll-like receptor 9 gene polymorphisms and risk of bacterial meningitis in a Chinese population. Genetics and Molecular Research 15(3), 25. doi: 10.4238/gmr.15037641.Google ScholarPubMed
van Well, GT et al. (2012) Polymorphisms in Toll-like receptors 2, 4, and 9 are highly associated with hearing loss in survivors of bacterial meningitis. PLoS ONE 7, e35837.CrossRefGoogle ScholarPubMed
Gowin, E et al. (2017) Analysis of TLR2, TLR4, and TLR9 single nucleotide polymorphisms in children with bacterial meningitis and their healthy family members. International Journal of Infectious Diseases 60, 2328.CrossRefGoogle ScholarPubMed
Higgins, JP and Thompson, SG (2002) Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 21, 15391558.CrossRefGoogle ScholarPubMed
Higgins, JP et al. (2003) Measuring inconsistency in meta-analyses. BMJ 327, 557560.CrossRefGoogle ScholarPubMed
Mantel, N and Haenszel, W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 22, 719748.Google ScholarPubMed
DerSimonian, R and Laird, N (1986) Meta-analysis in clinical trials. Controlled Clinical Trials 7, 177188.CrossRefGoogle ScholarPubMed
Begg, CB and Mazumdar, M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 10881101.CrossRefGoogle Scholar
Edwards, AWF (2008) GH Hardy (1908) and Hardy–Weinberg equilibrium. Genetics 179, 11431150.CrossRefGoogle Scholar
Davis, LE (2018) Acute bacterial meningitis. Continuum Neuroinfectious Disease 24, 12641283.Google ScholarPubMed
Tan, J et al. (2015) Clinical prognosis in neonatal bacterial meningitis: the role of cerebrospinal fluid protein. PLoS ONE 10, e0141620.CrossRefGoogle ScholarPubMed
Klinger, G et al. (2000) Predicting the outcome of neonatal bacterial meningitis. Pediatrics 106, 477482.CrossRefGoogle ScholarPubMed
Stevens, JP et al. (2003) Long term outcome of neonatal meningitis. Archives of Disease in Childhood: Fetal and Neonatal Edition 88, F179F184.CrossRefGoogle ScholarPubMed
Chang, CJ et al. (2004) Bacterial meningitis in infants: the epidemiology, clinical features, and prognostic factors. Brain & Development 26, 168175.CrossRefGoogle ScholarPubMed
de Louvois, J, Halket, S and Harvey, D (2005) Neonatal meningitis in England and Wales: sequelae at 5 years of age. European Journal of Pediatrics 164, 730734.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1. Flow diagram for identification of eligible studies for this meta-analysis.

Figure 1

Table 1. Main characteristics of the case-control studies included in meta-analysis

Figure 2

Table 2. Meta-analysis of the TLR9 rs352140 polymorphism with BM risk

Supplementary material: Image

Xue et al. supplementary material

Xue et al. supplementary material

Download Xue et al. supplementary material(Image)
Image 718.6 KB